Three independent discounted-cash-flow-style models value Indivior Pharmaceuticals, Inc. Common Stock every trading day. 2 of 3 currently price INDV above its market price.
| Free Cash Flow model | $36.73 |
| Excess Profit model | $48.45 |
| Residual Earnings model | $-0.48 |
| Dividend Discount model | $198.50 |
| Piotroski F-Score | 2 / 4 |
| Return on invested capital | +71.9% |
| Net debt / EBITDA | 0.7× |
| Gross margin | +80.1% |
| Revenue CAGR | — |
| Cash conversion | -0.1× |
| Dividend yield | +22.6% |
| Buyback yield | — |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open INDV in StockKitty